Latest news from Iconovo

Iconovo to present at Redeye Life Science Day November 23

Johan Wäborg, CEO, will present Iconovo at Redeye Life Science Day. Learn more about why you should invest in Iconovo and get excited by our vision to…

Busy days for Iconovo at BIO-Europe

Iconovo had three hectic days at BIO-Europe, with a large number of meetings with potential partners. The company especially highlighted their latest innovation,…

Iconovo and Arcede Pharma take the next step in the development of a new treatment for COPD

Iconovo AB (publ), which develops complete inhalation products for a global market, and Arcede Pharma, which develops inhalation treatments for COPD and…

Meet us

BUSINESS MEETINGS

Nordic Life Science Days 

November 29-30, 2023

Copenhagen

DDL, Drug Delivery to the Lungs

December 6-8, 2023

Edinburgh

BIO-Europe Spring

March 18-20, 2023

Barcelona

RDD, Respiratory Drug Delivery 2024

May 5-9, 2024

JW Marriott Starr Pass, Tuscon, Arizona

Bio International Convention

June 3-6, 2024

San Diego Convention Center – San Diego, CA

INVESTOR MEETINGS

Redeye Life Science Days 

November 28, Stockholm

We are a specialized CDMO that develops inhalation products in our patented, innovative inhalers, supporting customers in bringing their inhaled treatments to market.

Learn more

PRODUCTS

Four differentiated technical platforms

We develop inhaled medicines from your drug substance as your complete inhalation partner. We take you all the way through your pharmaceutical product development, from idea to finalized inhalation product. Our strength is the integrated development of inhaler and dry powder formulation. Four differentiated technical inhaler platforms can be optimized with your unique dry powder formulation, and we also assist with manufacturing of clinical trial material in early clinical trials and technical documentation for registrations.

Learn more

DEVELOPMENT RESOURCES

Engineering and pharmaceutical expertise

Iconovo has an integrated development process, with all competences and facilities inhouse. With a unique combination of engineering and pharmaceutical expertise, our capabilities include devices, formulation, pharmaceutical analysis, and advisory services.

Learn more

Stay up to date with Iconovo’s news and press releases